Cite

HARVARD Citation

    Zheng, Q. et al. (2015). Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer. Medicine. 94 (40), pp. e1718-. [Online]. 
  
Back to record